Skip to main content

Table 2 Comparison of the intercept and slope to explain the effect of β2-agonists by IPD

From: Many continuous variables should be analyzed using the relative scale: a case study of β2-agonists for preventing exercise-induced bronchoconstriction

 

Intercept

Slope

χ2(3 df) *

P *

AIC **

Uniform effect (absolute scale)

27.7

  

1638.3

Intercept and slope

7.9

−0.69

82.3

10−17

 

Slope (relative scale)

−0.90

13.9

0.003

1576.8

  1. The intercept and the slope were calculated with a linear mixed-effects model using the type of β2-agonist and study as grouping variables. The intercept alone indicates that β2-agonists decrease the post-exercise FEV1 decline by an absolute effect of 27.7 pp. (95% CI: 22.1 to 33.4 pp). The slope alone indicates that β2-agonists decrease the post-exercise FEV1 decline by a relative effect of 90% (95% CI: 72% to 109%). Abbreviations: pp., percentage points
  2. * Anova test comparing the model on the row with the model on the row above
  3. ** AIC, Akaike information criterion. AIC estimates the relative quality of statistical models, lower AIC value is preferable